Last updated 2026-07-20
- Raised $10M Series A, Oct 2011
Total raised
$10.0M
Last: Undisclosed Round 2011-11
Stage
Mature
Founded
2006
Headcount
82
HQ
Caesarea, Israel
Sector
Health Tech & Life Sciences
About
Arineta is an Israeli company dedicated to advancing cardiovascular imaging solutions through cutting-edge technology. The company develops and produces innovative cardiovascular imaging solutions, with its flagship product being SpotLight™ Duo, the world's first dedicated single-heartbeat, whole-heart Cardiovascular and Thoracic CT scanner. Arineta's technology is based on proprietary Stereo CT technology and aims to make cardiac CT the front-line non-invasive test for diagnosing, therapy planning, and monitoring cardiovascular disease. The company's team includes scientists who are inventors of the multi-slice spiral CT technology.
Funding history · 1 round · $10.0M total
2011-10
A Round
$10.0M
Headcount over time
From 53 (2017-06) to 88 (2026-01) · +35 (+66%) · 58 points · source: Finder history + radar grounding
Q&A
- What is Arineta's primary focus?
- Arineta specializes in developing and producing cardiovascular imaging solutions, with its flagship product being CardioGraphe, a dedicated cardiac CT scanner.
- What is CardioGraphe?
- CardioGraphe is Arineta's proprietary single-heartbeat, whole-heart cardiac CT scanner based on Stereo CT technology, designed for comprehensive clinical information in cardiac diagnosis and therapy planning.
- What are the key features of Arineta's CardioGraphe system?
- CardioGraphe offers 140-mm coverage at a rotation speed of 0.24 seconds per rotation, uses a lower radiation dose than whole-body CT scanners, and reduces contrast volumes and the need for beta blockers.
- Who distributes Arineta's CardioGraphe globally?
- GE Healthcare is the global distributor for Arineta's CardioGraphe product.
- In which regions does CardioGraphe have regulatory clearance and operate?
- CardioGraphe has regulatory clearance in the United States, Canada, European Union, and other regions, and is installed in hospitals in North America, Europe, China, and Israel.
- When was Arineta founded?
- Arineta was founded in June 2006.
- What is the total amount of funding Arineta has raised?
- Arineta has raised a total of $10,000,000 USD.
- When was Arineta's last funding round?
- Arineta's last funding round occurred in November 2011, raising $10,000,000 USD.
Team · 2
Yosi Morik
Founder · Founder
Ehud Dafni
Founder · Founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & TherapeuticsDiagnostics Devices
Technologies
Simulation & Imaging
Target customers
Healthcare & Life SciencesHealthcareProvidersCommerce & RetailDistribution ChannelsDistributor
Business model
B2B
Highlights
1 Patents
Tags
diagnosticsimagingcardiovascularpatent-pendinghospitalsmedical-devicesct-scancardiologytherapeuticsoptronicsmedical-technologies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | arineta.com |
|---|---|
| linkedin.com/company/9485382 | |
| facebook.com/arinetaltd |
Identifiers & details
| Legal name | Arineta Ltd. |
|---|---|
| Founded | 2006-6 |
| Employees (exact) | 82 |
Radar intelligence
Patents
| EPO | 21 |
|---|
Publications (Crossref)
| Works | 1 |
|---|
Web history (Wayback)
| Domain | arineta.com |
|---|
Certificate / subdomain footprint
| Subdomains | 7 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 513842740 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2006-06-14 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 4 — people (2), other (1), shares_capital (1) |
| Registered address | חלמיש 15 קיסריה |
Recent registry events
| Date | Event |
|---|---|
| 2025-11-27 | עדכון דירקטורים-הוספת דירקטור |
| 2026-03-24 | עדכון דירקטורים-הסרת דירקטור |
| 2026-03-08 | שינוי בתקנון |
| 2026-03-05 | הגדלה של הון רשום |